ME

Mohan Eknath Tulapurkar

Active Director Designated Partner DIN 09245574
DIN 09245574 First appointment Jul 2021 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohan Eknath Tulapurkar

Data last updated:

Mohan Eknath Tulapurkar is a Designated Partner at Cedar Biosciences Llp (since 2021). The company operates in Research & Development.

DIN 09245574
Primary Designation Designated Partner
Industry Research & Development
First Appointment 19 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jul 20212021Active

Board colleagues of Mohan Eknath Tulapurkar

NameDINCompanyDesignation
Girish Shreedhar Kulkarni09245573Cedar Biosciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cedar Biosciences Llp
Premium access

Shareholding and investment profile for Mohan Eknath Tulapurkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohan Eknath Tulapurkar

Mohan Eknath Tulapurkar currently holds 1 directorship: Cedar Biosciences Llp (Designated Partner, since 19 Jul 2021).

Mohan Eknath Tulapurkar was first appointed on 19 Jul 2021 as Designated Partner at Cedar Biosciences Llp.

The current boards of Mohan Eknath Tulapurkar's companies include Girish Shreedhar Kulkarni (Cedar Biosciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available